Holzapfel K, Eiber MJ, Fingerle AA, et al. Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods. Abdominal Radiology 2012; 37: 74–82.
Schmid-Tannwald C, Reiser MF, Zech CJ. Diffusion-weighted magnetic resonance imaging of the abdomen. Radiologe 2011; 51: 195–204.
Wang Y, Miller FH, Chen ZE, et al. Diffusion-weighted MR imaging of solid and cystic lesions of the pancreas. RadioGraphics 2011; 31: 47–64.
Razek AAKA, Abdalla A, Barakat T, et al. Assessment of the liver and spleen in children with Gaucher disease type I with diffusion-weighted MR imaging. Blood Cells, Molecules, and Diseases 2018; 68: 139–142.
Ljimani A, Caroli A, Laustsen C, et al. Consensus-based technical recommendations for clinical translation of renal diffusion-weighted MRI. MAGMA 2020; 33: 177–195.
Onur MR, Ozturk F, Aygun C, et al. Role of the apparent diffusion coefficient in the differential diagnosis of gastric wall thickening. Journal of Magnetic Resonance Imaging 2012; 36: 672–677.
van Rossum PS, van Lier AL, van Vulpen M, et al. Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer. Radiotherapy and Oncology 2015; 115: 163–170.
Liu S, Wang H, Guan W, et al. Preoperative apparent diffusion coefficient value of gastric cancer by diffusion-weighted imaging: Correlations with postoperative TNM staging. Journal of Magnetic Resonance Imaging 2015; 42: 837–843.
Neubauer H, Pabst T, Dick A, et al. Small-bowel MRI in children and young adults with Crohn disease: Retrospective head-to-head comparison of contrast-enhanced and diffusion-weighted MRI. Pediatric Radiology 2013; 43: 103–114.
Buisson A, Petitcolin V. Commentary: Diffusion-weighted magnetic resonance imaging—A novel way to assess disease activity in Crohnʼs disease? Authorsʼ reply. Alimentary Pharmacology & Therapeutics 2013; 37: 834.
Seo N, Park SH, Kim KJ, et al. MR enterography for the evaluation of small-bowel inflammation in Crohn’s disease by using diffusion-weighted imaging without intravenous contrast material: A prospective noninferiority study. Radiology 2016; 278: 762–772.
Oussalah A, Laurent V, Bruot O, et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 2010; 59: 1056–1065
Solak A, Genc B, Solak I, et al. The value of diffusion-weighted magnetic resonance imaging in the differential diagnosis in diffuse bowel wall thickening. Turkish Journal of Gastroenterology 2013; 24: 154–160.
Hosonuma T, Tozaki M, Ichiba N, et al. Clinical usefulness of diffusion-weighted imaging using low and high b-values to detect rectal cancer. Magnetic Resonance in Medical Sciences 2006; 5: 173–177.
Akashi M, Nakahusa Y, Yakabe T, et al. Assessment of aggressiveness of rectal cancer using 3-T MRI: Correlation between the apparent diffusion coefficient as a potential imaging biomarker and histologic prognostic factors. Acta Radiologica 2014; 55: 524–531.
Soussan M, Des Guetz G, Barrau V, et al. Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy. European Radiology 2012; 22: 1479–1487.
